Literature DB >> 22445006

Quality assurance peer review chart rounds in 2011: a survey of academic institutions in the United States.

Yaacov Richard Lawrence1, Michal A Whiton, Zvi Symon, Evan J Wuthrick, Laura Doyle, Amy S Harrison, Adam P Dicker.   

Abstract

PURPOSE: In light of concerns regarding the quality of radiation treatment delivery, we surveyed the practice of quality assurance peer review chart rounds at American academic institutions. METHODS AND MATERIALS: An anonymous web-based survey was sent to the chief resident of each institution across the United States.
RESULTS: The response rate was 80% (57/71). The median amount of time spent per patient was 2.7 minutes (range, 0.6-14.4). The mean attendance by senior physicians and residents was 73% and 93%, respectively. A physicist was consistently present at peer review rounds in 66% of departments. There was a close association between attendance by senior physicians and departmental organization: in departments with protected time policies, good attendance was 81% vs. 31% without protected time (p = 0.001), and in departments that documented attendance, attending presence was 69% vs. 29% in departments without documentation (p < 0.05). More than 80% of institutions peer review all external beam therapy courses; however, rates were much lower for other modalities (radiosurgery 58%, brachytherapy 40%-47%). Patient history, chart documentation, and dose prescription were always peer reviewed in >75% of institutions, whereas dosimetric details (beams, wedges), isodose coverage, intensity-modulated radiation therapy constraints, and dose-volume histograms were always peer reviewed in 63%, 59%, 42%, and 50% of cases, respectively. Chart rounds led to both minor (defined as a small multileaf collimator change/repeated port film) and major (change to dose prescription or replan with dosimetry) treatment changes. Whereas at the majority of institutions changes were rare (<10% of cases), 39% and 11% of institutions reported that minor and major changes, respectively, were made to more than 10% of cases.
CONCLUSION: The implementation of peer review chart rounds seems inconsistent across American academic institutions. Brachytherapy and radiosurgical procedures are rarely reviewed. Attendance by senior physicians is variable, but it improves when scheduling clashes are avoided. The potential effect of a more thorough quality assurance peer review on patient outcomes is not known.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22445006     DOI: 10.1016/j.ijrobp.2012.01.029

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  Impact of Neuroradiology-Based Peer Review on Head and Neck Radiotherapy Target Delineation.

Authors:  S Braunstein; C M Glastonbury; J Chen; J M Quivey; S S Yom
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-03       Impact factor: 3.825

2.  Impact of the introduction of weekly radiotherapy quality assurance meetings at one UK cancer centre.

Authors:  C V Brammer; L Pettit; R Allerton; M Churn; M Joseph; P Koh; I Sayers; M King
Journal:  Br J Radiol       Date:  2014-09-24       Impact factor: 3.039

3.  Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy.

Authors:  Carlos E Cardenas; Abdallah S R Mohamed; Randa Tao; Andrew J R Wong; Mussadiq J Awan; Shirly Kuruvila; Michalis Aristophanous; G Brandon Gunn; Jack Phan; Beth M Beadle; Steven J Frank; Adam S Garden; William H Morrison; Clifton D Fuller; David I Rosenthal
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-11-19       Impact factor: 7.038

4.  Attitudes and access to resources and strategies to improve quality of radiotherapy among US radiation oncologists: A mixed methods study.

Authors:  Y Helen Zhang; Elaine Cha; Kathleen Lynch; Renee Gennarelli; Jeffrey Brower; Michael V Sherer; Daniel W Golden; Susan Chimonas; Deborah Korenstein; Erin F Gillespie
Journal:  J Med Imaging Radiat Oncol       Date:  2022-06-01       Impact factor: 1.667

Review 5.  Metrics to evaluate the performance of auto-segmentation for radiation treatment planning: A critical review.

Authors:  Michael V Sherer; Diana Lin; Sharif Elguindi; Simon Duke; Li-Tee Tan; Jon Cacicedo; Max Dahele; Erin F Gillespie
Journal:  Radiother Oncol       Date:  2021-05-11       Impact factor: 6.901

6.  Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary.

Authors:  Lawrence B Marks; Robert D Adams; Todd Pawlicki; Albert L Blumberg; David Hoopes; Michael D Brundage; Benedick A Fraass
Journal:  Pract Radiat Oncol       Date:  2013-03-16

7.  Analysis of a real time group consensus peer review process in radiation oncology: an evaluation of effectiveness and feasibility.

Authors:  Ashley A Albert; William N Duggar; Rahul P Bhandari; Toms Vengaloor Thomas; Satyaseelan Packianathan; Robert M Allbright; Madhava R Kanakamedala; Divyang Mehta; Chunli Claus Yang; Srinivasan Vijayakumar
Journal:  Radiat Oncol       Date:  2018-12-03       Impact factor: 3.481

8.  The Impact of Transitioning to Prospective Contouring and Planning Rounds as Peer Review.

Authors:  Murat Surucu; Amishi Bajaj; John C Roeske; Alec M Block; Jennifer Price; William Small; Abhishek A Solanki
Journal:  Adv Radiat Oncol       Date:  2019-03-21

9.  100% peer review in radiation oncology: is it feasible?

Authors:  E Martin-Garcia; F Celada-Álvarez; M J Pérez-Calatayud; M Rodriguez-Pla; O Prato-Carreño; D Farga-Albiol; O Pons-Llanas; S Roldán-Ortega; E Collado-Ballesteros; F J Martinez-Arcelus; Y Bernisz-Diaz; V A Macias; J Chimeno; J Gimeno-Olmos; F Lliso; V Carmona; J C Ruiz; J Pérez-Calatayud; A Tormo-Micó; A J Conde-Moreno
Journal:  Clin Transl Oncol       Date:  2020-06-15       Impact factor: 3.405

10.  Three discipline collaborative radiation therapy (3DCRT) special debate: Peer review in radiation oncology is more effective today than 20 years ago.

Authors:  Anis Ahmad; Lakshmi Santanam; Abhishek A Solanki; Laura Padilla; Erina Vlashi; Patrizia Guerrieri; Michael M Dominello; Jay Burmeister; Michael C Joiner
Journal:  J Appl Clin Med Phys       Date:  2020-11-24       Impact factor: 2.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.